1. Home
  2. CLPS vs CVM Comparison

CLPS vs CVM Comparison

Compare CLPS & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CLPS Incorporation

CLPS

CLPS Incorporation

SELL

Current Price

$0.81

Market Cap

28.3M

Sector

Technology

ML Signal

SELL

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

N/A

Current Price

$1.33

Market Cap

24.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLPS
CVM
Founded
2005
1983
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
24.1M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
CLPS
CVM
Price
$0.81
$1.33
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
8.9K
★ 98.0K
Earning Date
10-16-2026
11-24-2026
Dividend Yield
★ 14.94%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 65.45
52 Week Low
$0.80
$0.89
52 Week High
$1.24
$7.80

Technical Indicators

Market Signals
Indicator
CLPS
CVM
Relative Strength Index (RSI) 40.55 36.57
Support Level $0.86 $1.19
Resistance Level $0.95 $1.52
Average True Range (ATR) 0.07 0.15
MACD -0.01 -0.01
Stochastic Oscillator 31.58 10.17

Price Performance

Historical Comparison
CLPS
CVM

About CLPS CLPS Incorporation

CLPS Inc is information technology, consulting and solutions service provider, focused on delivering services mainly to world-wide institutions, including banking, wealth management, ecommerce, and automotive areas both in China and globally. It has been at the forefront of driving digital transformation and optimizing operational efficiency across industries through innovations in artificial intelligence (AI), cloud computing, and data. It diverse business lines span sectors including fintech, payment and credit services, e-commerce, education and study abroad programs, and world-wide tourism integrated with transportation services. Its segments are IT services and academic education service. Majority of revenue comes from IT services segment. Its products are NiBot RPA, and CAKU.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: